US Stock MarketDetailed Quotes
ZVRA Zevra Therapeutics
- 6.300
- 0.0000.00%
Close Aug 2 16:00 ET
- 9.030
- +2.730+43.33%
Post 20:02 ET
263.68MMarket Cap-4772P/E (TTM)
0.000High0.000Low556.13KVolume6.300Open6.300Pre Close4.85MTurnover1.54%Turnover RatioLossP/E (Static)41.85MShares7.28052wk High5.40P/B227.28MFloat Cap3.89052wk Low--Dividend TTM36.08MShs Float418.400Historical High--Div YieldTTM0.00%Amplitude2.560Historical Low8.713Avg Price1Lot Size
About Zevra Therapeutics Company
Zevra Therapeutics, Inc. is a clinical-stage specialty pharmaceutical company, which engages in the discovery and development of proprietary prodrugs. It focuses on the treatment of serious medical conditions such as attention deficit hyperactivity disorder, pain, and other central nervous system disorders through its platform technology known as Ligand Activated Therapy. The company was founded by Christal M. M. Mickle and Travis C. Mickle on October 30, 2006 and is headquartered in Celebration, FL.
Company Profile
SymbolZVRA
Company NameZevra Therapeutics
Listing DateApr 16, 2015
Founded2006
CEOMr. Neil F. McFarlane, M.S.
MarketNASDAQ
Employees69
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address1180 Celebration Boulevard,Suite 103
CityCelebration
ProvinceFlorida
CountryUnited States of America
Zip Code34747
Phone1-321-939-3416
Websitehttp://zevra.com
Company Executives
- Name
- Position
- Salary
- Neil F. McFarlane, M.S.
- Director, President and Chief Executive Officer
- 3.45M
- Christal M M. Mickle, M.A.
- Chief Development Officer
- 1.67M
- Joshua Schafer, M.B.A.
- Chief Commercial Officer and Executive Vice President, Business Development
- 1.82M
- Dr. Sven Guenther, PhD
- Chief Scientific Officer
- --
- R. LaDuane Clifton, C.P.A.,M.B.A.
- Chief Financial Officer, Secretary and Treasurer
- 2.26M
- Dr. Adrian Quartel, M.D.
- Chief Medical Officer
- --
- Timothy J. Sangiovanni
- Senior Vice President, Corporate Controller and Principal Accounting Officer
- --
- Tamara A. Favorito
- Chairman of the Board
- 324.39K
- Dr. Alvin Shih, M.D.
- Director
- --
- Corey Watton
- Independent Director
- 260.67K
- John B. Bode
- Independent Director
- 264.31K
- Douglas W. Calder
- Independent Director
- 258.02K
- Dr. Wendy L. Dixon, PhD
- Independent Director
- 274.00K
- Thomas Anderson
- Independent Director
- 243.04K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg